復宏漢霖(2696.HK)預計年度盈利逾5億元 近期獲多家大行首次覆蓋給予“買入”評級 最高目標價20.50港元
復宏漢霖(2696.HK)公吿,公司預計截至2023年12月31日止年度將錄得年內利潤不低於人民幣5億元,而截至2022年12月31日止年度的年內虧損約為人民幣6.95億元。此乃集團繼於截至2023年6月30日止六個月實現首次半年度盈利之後,首次實現全年度盈利。集團於報吿期內首次實現全年度盈利,主要是由於:集團核心產品漢曲優覆蓋的患者數量持續增長,漢曲優於報吿期內的盈利能力獲得提升。集團創新產品漢斯狀自2022年3月上市以來銷售收入持續提高。集團持續加強精細化管理措施,在成本控制方面取得成果。光大證券首次覆蓋研報中提出考慮到公司優秀的經營質量、強大的產品力、國際化的拓展空間,給予公司“買入”評級,給予公司目標價18.62元,按最新匯率換算為20.50港元。天風證券首次覆蓋公司,認為公司業績已進入高速增長期,2023年上半年已經歷史性實現盈虧平衡。考慮到後續公司創新管線及海外佈局均有望迎來收穫期,給予買入評級,目標價19.43港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.